These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 9398693

  • 1. Acid-labile subunit of human insulin-like growth factor-binding protein complex: measurement, molecular, and clinical evaluation.
    Khosravi MJ, Diamandi A, Mistry J, Krishna RG, Khare A.
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3944-51. PubMed ID: 9398693
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [Abstract] [Full Text] [Related]

  • 4. Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex.
    Baxter RC.
    J Clin Endocrinol Metab; 1990 May; 70(5):1347-53. PubMed ID: 1692332
    [Abstract] [Full Text] [Related]

  • 5. Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Fukuda I, Hizuka N, Itoh E, Yasumoto K, Ishikawa Y, Murakami Y, Sata A, Takano K.
    Endocr J; 2002 Jun; 49(3):379-86. PubMed ID: 12201224
    [Abstract] [Full Text] [Related]

  • 6. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs.
    Lee CY, Rechler MM.
    Endocrinology; 1995 Nov; 136(11):4982-9. PubMed ID: 7588232
    [Abstract] [Full Text] [Related]

  • 7. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency.
    Juul A, Møller S, Mosfeldt-Laursen E, Rasmussen MH, Scheike T, Pedersen SA, Kastrup KW, Yu H, Mistry J, Rasmussen S, Müller J, Henriksen J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4408-15. PubMed ID: 9851786
    [Abstract] [Full Text] [Related]

  • 8. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P, Zwimpfer C, Zapf J, Schmid C.
    Acta Obstet Gynecol Scand; 2006 Dec; 85(8):900-5. PubMed ID: 16862465
    [Abstract] [Full Text] [Related]

  • 9. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
    Gargosky SE, Wilson KF, Fielder PJ, Vaccarello MA, Guevara-Aguirre J, Diamond FB, Baxter RC, Rosenbloom AL, Rosenfeld RG.
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
    [Abstract] [Full Text] [Related]

  • 10. Sample pre-treatment determines the clinical usefulness of acid-labile subunit immunoassays in the diagnosis of growth hormone deficiency and acromegaly.
    Morrison KM, Bidlingmaier M, Stadler S, Wu Z, Skriver L, Strasburger CJ.
    Eur J Endocrinol; 2007 Mar; 156(3):331-9. PubMed ID: 17322493
    [Abstract] [Full Text] [Related]

  • 11. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 12. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
    Schmid C, Zwimpfer C, Brändle M, Krayenbühl PA, Zapf J, Wiesli P.
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
    [Abstract] [Full Text] [Related]

  • 13. The high molecular weight insulin-like growth factor-binding protein complex: epitope mapping, immunoassay, and preliminary clinical evaluation.
    Khosravi J, Diamandi A, Mistry J, Krischna RG.
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2826-33. PubMed ID: 10443687
    [Abstract] [Full Text] [Related]

  • 14. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [Abstract] [Full Text] [Related]

  • 15. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children.
    Mandel SH, Moreland E, Rosenfeld RG, Gargosky SE.
    Endocrine; 1997 Dec; 7(3):351-60. PubMed ID: 9657073
    [Abstract] [Full Text] [Related]

  • 16. A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially.
    Lee CY, Rechler MM.
    Endocrinology; 1995 Feb; 136(2):668-78. PubMed ID: 7530649
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of the 150-kilodalton insulin-like growth factor-binding protein-3 ternary complex by continuous and pulsatile patterns of growth hormone (GH) administration in GH-deficient patients.
    Laursen T, Flyvbjerg A, Jørgensen JO, Baxter RC, Christiansen JS.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4310-4. PubMed ID: 11095473
    [Abstract] [Full Text] [Related]

  • 18. Quantitative ontogeny of murine insulin-like growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acid-labile subunit.
    Hwang DL, Lee PD, Cohen P.
    Growth Horm IGF Res; 2008 Feb; 18(1):65-74. PubMed ID: 17719253
    [Abstract] [Full Text] [Related]

  • 19. Decreased serum levels of acid-labile subunit in patients with anorexia nervosa.
    Fukuda I, Hotta M, Hizuka N, Takano K, Ishikawa Y, Asakawa-Yasumoto K, Tagami E, Demura H.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2034-6. PubMed ID: 10372706
    [Abstract] [Full Text] [Related]

  • 20. Immunoblot studies of the IGF-related acid-labile subunit.
    Liu F, Hintz RL, Khare A, Diaugustine RP, Powell DR, Lee PD.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1883-6. PubMed ID: 7527417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.